Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONSIST: Glycine or d-cycloserine in Schizophrenia
NCT00222235Phase 3Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jan 2000
- Primary completion
- Jun 2004
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of d-cycloserine, glycine in schizophrenia, schizoaffective disorder, sponsored by University of Maryland, Baltimore. Started Jan 2000; status: completed.
02
Drugs
d-cycloserineglycine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00222235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00222235.